Cochrane Abstracts
Antifibrotic therapies for idiopathic pulmonary fibrosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Antifibrotic Therapies for Idiopathic Pulmonary Fibrosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434008/all/Antifibrotic_therapies_for_idiopathic_pulmonary_fibrosis.
Antifibrotic therapies for idiopathic pulmonary fibrosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434008/all/Antifibrotic_therapies_for_idiopathic_pulmonary_fibrosis. Accessed December 27, 2024.
Antifibrotic therapies for idiopathic pulmonary fibrosis. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434008/all/Antifibrotic_therapies_for_idiopathic_pulmonary_fibrosis
Antifibrotic Therapies for Idiopathic Pulmonary Fibrosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 December 27]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434008/all/Antifibrotic_therapies_for_idiopathic_pulmonary_fibrosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Antifibrotic therapies for idiopathic pulmonary fibrosis
ID - 434008
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434008/all/Antifibrotic_therapies_for_idiopathic_pulmonary_fibrosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
